Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
MorphoSys AG - American Depositary Shares
(NQ:
MOR
)
18.96
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
18.96
Bid (Size)
17.81 (3)
Ask (Size)
19.00 (10)
Prev. Close
18.96
Today's Range
18.96 - 18.96
52wk Range
8.280 - 19.50
Shares Outstanding
32,890,046
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Morpheus Launches $20 Million In Rewards For AI Compute Providers
December 11, 2024
Morpheus, a decentralized platform for deploying AI-driven “Smart Agents,” has launched a $20 million reward program for compute providers.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting
August 27, 2024
Via
ACCESSWIRE
Performance
YTD
+96.68%
+96.68%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+4.29%
+4.29%
1 Year
+103.87%
+103.87%
More News
Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, MOR, AFBI on Behalf of Shareholders
July 17, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
3 Global Stocks to Buy to Escape the Volatility on Wall Street
July 16, 2024
Via
InvestorPlace
MorphoSys: Q4 Earnings Insights
March 13, 2024
Via
Benzinga
Earnings Outlook For MorphoSys
March 12, 2024
Via
Benzinga
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
July 12, 2024
From
MorphoSys AG
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DM, SHCR, MOR, ALE on Behalf of Shareholders
July 08, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALLG, MOR, BEST, MGOL on Behalf of Shareholders
June 29, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders
June 20, 2024
From
Halper Sadeh LLC
Via
Business Wire
MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
June 20, 2024
From
MorphoSys AG
Via
Business Wire
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
June 19, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
May 27, 2024
Via
Benzinga
MOR Stock Earnings: MorphoSys Misses EPS, Misses Revenue for Q1 2024
April 30, 2024
Via
InvestorPlace
MorphoSys AG Reports First Quarter 2024 Financial Results
April 29, 2024
From
MorphoSys AG
Via
Business Wire
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, Pelabresib
April 29, 2024
Via
Benzinga
Exposures
Product Safety
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
April 24, 2024
Via
ACCESSWIRE
Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
April 23, 2024
Via
Benzinga
MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
April 11, 2024
From
MorphoSys AG
Via
Business Wire
MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
April 11, 2024
Via
ACCESSWIRE
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
March 21, 2024
Via
ACCESSWIRE
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 13, 2024
From
MorphoSys AG
Via
Business Wire
Earnings Scheduled For March 13, 2024
March 13, 2024
Via
Benzinga
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
March 09, 2024
Via
Talk Markets
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
March 07, 2024
Via
InvestorPlace
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.